As the only approved treatment to address disease progression, SKYCLARYS addresses a long-standing gap in the care of Canadians living with Friedreich's ataxia Friedreich's ...
Hosted on MSN28d
Biogen Stock Is Mutating Into a Value PlaySpinraza is a gene therapy used for treating a rare spinal muscular atrophy ... for patients with mild dementia or mild cognitive impairment. The drug targets the removal of amyloids, which ...
Affiliation: Center for Neurosciences, Orthopaedics, & Spine Occupational Medicine Doug Martin ... Dr. Raizman speaks nationally on Impairment Rating and has chaired and taught multiple courses for ...
California, Florida, Maryland and Texas are the states with the most ASCs included on U.S. News & World’s 2025 Best ...
U.S. News & World Report released its second annual “Best Ambulatory Surgery Centers” list, and more than 180 orthopedic ASCs ...
Here's what to know about Trump's approval rating, including how they are decided and how Trump's ratings compare with his first term and past presidents. Trump had a final approval rating of 34% ...
Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...
Donald Trump's presidential approval ratings held steady over the first month of his second term, despite mass firings of government workers and high price of eggs, but Americans' feelings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results